{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-001217","form_type":"8-K","ticker":"GKOS","cik":"0001192448","company_name":"GLAUKOS Corp","filed_at":"2025-02-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.104868+00:00","generated_at":"2026-05-26T08:04:36.792512+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Glaukos Q4 record net sales $105.5M, +28% YoY; guides FY2025 $475-485M","bullets":["Q4 net sales record $105.5M, +28% YoY; glaucoma segment $84.1M (+39%).","GAAP net loss ($0.60)/share vs ($0.75) prior year; non-GAAP net loss ($0.40).","FY 2024 net sales $383.5M (+22% YoY); net loss $146.4M ($2.77/share).","Cash $324M, no debt; 2025 revenue guidance $475-485M.","Q4 GAAP gross margin 73%; non-GAAP gross margin 82%."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-001217","json":"https://secwatch.observer/filing/0001558370-25-001217.json","markdown":"https://secwatch.observer/filing/0001558370-25-001217.md","text":"https://secwatch.observer/filing/0001558370-25-001217.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1192448/000155837025001217/0001558370-25-001217-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1192448/000155837025001217/gkos-20250220x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T08:04:36.792512+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}